2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine

BACKGROUND: NasoVAX is a replication-deficient adenovirus-based vaccine designed to express influenza hemagglutinin in nasal epithelial cells when given as a nasal spray. In preclinical studies, NasoVAX was associated with divergent strain protection. Prior preclinical and clinical studies with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasker, Sybil, Krishnan, Vyjayanthi, Bart, Stephan, Suyundikov, Anvar, Booth, Peta-Gay, Wight O’Rourke, Anna, Zhang, Jianfeng, Georges, Bertrand, Roberts, Scot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253025/
http://dx.doi.org/10.1093/ofid/ofy209.162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253025/
http://dx.doi.org/10.1093/ofid/ofy209.162

Ejemplares similares